Axis Direct is bullish on Divi's Laboratories has recommended buy rating on the stock with a target price of Rs 1080 in its research report dated October 03, 2017.
In an interview to CNBC-TV18, Amey Chalke, Research Analyst of HDFC Securities spoke about the latest happenings in pharma sector and shared his views on various stocks.
Sharekhan is recommended hold rating on Divi’s Laboratories with a target price of Rs 1040 in its research report dated September 20, 2017.
Pharma stocks have been on an upward trend. In an interview to CNBC-TV18, Deepak Malik, Pharma Analyst of Edelweiss Securities discussed what is happening in the sector.
Divis Laboratories, Dr Reddy's Laboratories, Aurobindo Pharma, Biocon and Lupin will get astrological support, says Satish Gupta of astrostocktips,
Ashwani Gujral of ashwanigujral.com is of the view that one can buy Bharti Airtel, Dr Reddy's Labs and Bharat Financial Inclusion and can sell Hero MotoCorp and Reliance Capital.
Sandeep Wagle of powermywealth.com advises buying NBCC and Divis Laboratories.
Sudarshan Sukhani of s2analytics.com is of the view that one can sell M&M and buy Ashok Leyland, Colgate Palmolive and Divis Laboratories.
Ashwani Gujral of ashwanigujral.com recommends buying VIP Industries and Divis Laboratories and feels that L&T is likely to test Rs 1400 in six months while he advises selling Arvind.
Ashwani Gujral of ashwanigujral.com suggests buying Motherson Sumi Systems, HPCL and Divis Laboratories.
According to Ashwani Gujral of ashwanigujral.com, one can buy Bajaj Auto, Sun TV, Mahindra Lifespace, Jai Corp, Balkrishna Industries, Indiabulls Real Estate and Divis Laboratories.
The ongoing re-inspection at Unit 2 of Divi's Laboratories remains in focus. In an interview to CNBC-TV18, Amey Chalke of HDFC Securities shared his expectations.
Sudarshan Sukhani of s2analytics.com is of the view that one can buy Bata India, Indraprastha Gas and M&M Financial Services and advises holding Jain Irrigation Systems while he suggests selling Rico Auto.
Divis Laboratories is sulking in trade today. Sources tell CNBC-TV18 that the unit 2 inspection is likely to end today or tomorrow.
is of the view that one can sell BHEL and can buy Canara Bank and Reliance Capital while he feels that Divis Labs can to rally to Rs 1000.
Ashwani Gujral of ashwanigujral.com is of the view that one can buy IIFL Holdings, Yes Bank, IGL and Bajaj Finance and feels that Divis Lab is likely to hit Rs 1000.
Ashwani Gujral of ashwanigujral.com recommends buying Divis Laboratories, Reliance Industries and HDFC Bank.
Ashwani Gujral of ashwanigujral.com recommends buying Berger Paints, REC and Wockhardt.
Divis Laboratories surging on hopes of re-inspection from US Food and Drug Administration (US FDA). Watch accompanying video of CNBC-TV18's Ekta Batra for more details.
Prakash Gaba of prakashgaba.com is of the view that Bharat Financial Inclusion can head towards Rs 1000.
According to Technical Analyst Prakash Gaba of prakashgaba.com, crucial support for the Nifty is at 9785 and the resistance is at 9911. Bank Nifty on the other hand has support at 24074 and resistance at 24511.
The company wants to modernise one of the two units by shifting non-production activities to proposed new area and meet all modern production facility compliances for achieving export targets.
Ashwani Gujral of ashwanigujral.com is of the view that one can buy Edelweiss Financial Services and Titan Company and can sell Sun Pharmaceutical Industries, Granules India and Divis Laboratories.
Expectation of some bit of consolidation cannot be ruled out in the coming week and investors will be better off taking bets on individual stocks.
Nifty likely to follow ‘Papa Dow’ which is riding the bull for last 8 years